These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35608860)

  • 81. The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer.
    Song Y; Qu T; Zhang H; Sun Y; Cui C; Chi Y; Zhang W; Wang X; Yang L
    Cancer Manag Res; 2021; 13():6199-6205. PubMed ID: 34393513
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
    Ou FS; Ahn DH; Dixon JG; Grothey A; Lou Y; Kasi PM; Hubbard JM; Van Cutsem E; Saltz LB; Schmoll HJ; Goldberg RM; Venook AP; Hoff P; Douillard JY; Hecht JR; Hurwitz H; Punt CJA; Koopman M; Bokemeyer C; Fuchs CS; Diaz-Rubio E; Tebbutt NC; Cremolini C; Kabbinavar FF; Bekaii-Saab T; Chibaudel B; Yoshino T; Zalcberg J; Adams RA; de Gramont A; Shi Q
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627145
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.
    Yin J; Dawood S; Cohen R; Meyers J; Zalcberg J; Yoshino T; Seymour M; Maughan T; Saltz L; Van Cutsem E; Venook A; Schmoll HJ; Goldberg R; Hoff P; Hecht JR; Hurwitz H; Punt C; Diaz Rubio E; Koopman M; Cremolini C; Heinemann V; Tournigard C; Bokemeyer C; Fuchs C; Tebbutt N; Souglakos J; Doulliard JY; Kabbinavar F; Chibaudel B; de Gramont A; Shi Q; Grothey A; Adams R
    Ther Adv Med Oncol; 2021; 13():17588359211020547. PubMed ID: 34262614
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Contemporary survival in metastatic bladder cancer patients: A population-based study.
    Di Bello F; Siech C; Jannello LMI; de Angelis M; Rodriguez Peñaranda N; Tian Z; Goyal JA; Baudo A; Collà Ruvolo C; Califano G; Creta M; Saad F; Shariat SF; Acquati P; de Cobelli O; Briganti A; Chun FKH; Micali S; Longo N; Karakiewicz PI
    Int J Cancer; 2024 Jul; ():. PubMed ID: 38958288
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review.
    Sarfraz Z; Sarfraz A; Farooq MD; Khalid M; Cheema K; Javad F; Khan T; Pervaiz Z; Sarfraz M; Jaan A; Sadiq S; Anwar J
    J Gastrointest Cancer; 2024 Sep; 55(3):1026-1057. PubMed ID: 38976079
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade.
    Avila J; Leone J; Vallejo CT; Leone JP
    Med Sci (Basel); 2024 Mar; 12(1):. PubMed ID: 38535156
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
    Goldberg RM; Adams R; Buyse M; Eng C; Grothey A; André T; Sobrero AF; Lichtman SM; Benson AB; Punt CJA; Maughan T; Burzykowski T; Sommeijer D; Saad ED; Shi Q; Coart E; Chibaudel B; Koopman M; Schmoll HJ; Yoshino T; Taieb J; Tebbutt NC; Zalcberg J; Tabernero J; Van Cutsem E; Matheson A; de Gramont A
    J Natl Cancer Inst; 2022 Jun; 114(6):819-828. PubMed ID: 34865086
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evolution of the Randomized Clinical Trial in the Era of Precision Oncology.
    Del Paggio JC; Berry JS; Hopman WM; Eisenhauer EA; Prasad V; Gyawali B; Booth CM
    JAMA Oncol; 2021 May; 7(5):728-734. PubMed ID: 33764385
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.
    McCleary NJ; Harmsen WS; Haakenstad E; Cleary JM; Meyerhardt JA; Zalcberg J; Adams R; Grothey A; Sobrero AF; Van Cutsem E; Goldberg RM; Peeters M; Tabernero J; Seymour M; Saltz LB; Giantonio BJ; Arnold D; Rothenberg ML; Koopman M; Schmoll HJ; Pitot HC; Hoff PM; Tebbutt N; Masi G; Souglakos J; Bokemeyer C; Heinemann V; Yoshino T; Chibaudel B; deGramont A; Shi Q; Lichtman SM
    JNCI Cancer Spectr; 2022 Mar; 6(2):. PubMed ID: 35603849
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020.
    Joshi U; Bhetuwal U; Yadav SK; Budhathoki P; Gaire S; Sharma S; Niu C; Low SK; Neupane N; Agrawal V; Poudyal BS; Dhakal P
    Clin Lymphoma Myeloma Leuk; 2024 Jul; ():. PubMed ID: 39095252
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Timing and Reporting of Secondary Overall Survival End Points for Phase III Trials in Advanced/Metastatic Disease.
    Freidlin B; Korde LA; Korn EL
    J Clin Oncol; 2023 Oct; 41(29):4616-4620. PubMed ID: 37471685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods.
    Seruga B; Pond GR; Hertz PC; Amir E; Ocana A; Tannock IF
    Ann Oncol; 2012 Nov; 23(11):2977-2982. PubMed ID: 22734009
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study.
    Gupta A; Gupta K; Roy AM; Attwood K; Gandhi A; Edge S; Takabe K; Repasky E; Yao S; Gandhi S
    Res Sq; 2023 Mar; ():. PubMed ID: 37034618
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Proportional Hazards Violations in Phase 3 Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.
    Lin TA; McCaw ZR; Koong A; Lin C; Abi Jaoude J; Patel R; Kouzy R; El Alam MB; Sherry AD; Noticewala SS; Fuller CD; Thomas CR; Sun R; Lee JJ; Lin R; Yuan Y; Shyr Y; Meirson T; Ludmir EB
    Clin Cancer Res; 2024 Aug; ():. PubMed ID: 39133081
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical atlas of rectal cancer highlights the barriers and insufficient interventions underlying the unfavorable outcomes in older patients.
    Zhao Z; Lin J; Chen S; Wang X; Wang H; Xu G; Wang J; Zhou R; Huang Z; Li Y; Zhang Y; Liu X; Wang P; Huang M; Luo Y; Yu H
    Heliyon; 2023 May; 9(5):e15966. PubMed ID: 37215849
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A).
    Kataoka K; Ouchi A; Suwa Y; Hirano H; Yamaguchi T; Takamizawa Y; Hanaoka M; Iguchi K; Boku S; Nagata K; Koyama T; Shimada Y; Inomata M; Sano Y; Mizusawa J; Hamaguchi T; Takii Y; Tsukamoto S; Takashima A; Kanemitsu Y;
    Eur J Surg Oncol; 2024 Jun; 50(6):108354. PubMed ID: 38657376
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Molecularly targeted therapy for metastatic colon cancer: proven treatments and promising new agents.
    El Zouhairi M; Charabaty A; Pishvaian MJ
    Gastrointest Cancer Res; 2011 Jan; 4(1):15-21. PubMed ID: 21464866
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
    Globus O; Sagie S; Lavine N; Barchana DI; Urban D
    PLoS One; 2023; 18(9):e0281561. PubMed ID: 37751439
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Improving Collection and Analysis of Overall Survival Data.
    Rodriguez LR; Gormley NJ; Lu R; Amatya AK; Demetri GD; Flaherty KT; Mesa RA; Pazdur R; Sekeres MA; Shan M; Snapinn S; Theoret MR; Umoja R; Vallejo J; Warren NJH; Xu Q; Anderson KC
    Clin Cancer Res; 2024 Sep; 30(18):3974-3982. PubMed ID: 39037364
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The ARCAD advanced colorectal cancer database--open for business.
    Buyse M; Sargent DJ; Goldberg RM; de Gramont A
    Ann Oncol; 2012 Jan; 23(1):281-282. PubMed ID: 22104572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.